Furthermore, Dox treatment of mice carrying MiaPaca-2-TREx cells was well tolerated and did not significantly reduce primary tumour weight, suggesting that Dox treatment per se would not confound growth regulatory effects of p16 induction (data not shown). The gene discussed is CDKN2A; the disease is neoplasm.